{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T03:13:23Z","timestamp":1783134803741,"version":"3.54.6"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Science Innovation Foundation of the First Affiliated Hospital of Xi'an Jiaotong University","award":["2016QN-11"],"award-info":[{"award-number":["2016QN-11"]}]},{"name":"Natural Science Basic Research Foundation of Shaanxi Province","award":["2017JQ8033"],"award-info":[{"award-number":["2017JQ8033"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81371798"],"award-info":[{"award-number":["81371798"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.intimp.2019.05.012","type":"journal-article","created":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T08:11:48Z","timestamp":1557821508000},"page":"156-162","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["PRDM1 levels are associated with clinical diseases in chronic HBV infection and survival of patients with HBV-related hepatocellular carcinoma"],"prefix":"10.1016","volume":"73","author":[{"given":"Na","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiude","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoge","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qunying","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengwen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10003","key":"10.1016\/j.intimp.2019.05.012_bb0005","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/S0140-6736(15)61412-X","article-title":"Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013","volume":"386","author":"Schweitzer","year":"2015","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.intimp.2019.05.012_bb0010","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1056\/NEJMra1001683","article-title":"Hepatocellular carcinoma","volume":"365","author":"El-Serag","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.intimp.2019.05.012_bb0015","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nri.2016.69","article-title":"Immune responses and immunopathology in acute and chronic viral hepatitis","volume":"16","author":"Shin","year":"2016","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2019.05.012_bb0020","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jhep.2010.10.016","article-title":"Enhanced B-cell differentiation and reduced proliferative capacity in chronic hepatitis C and chronic hepatitis B virus infections","volume":"55","author":"Oliviero","year":"2011","journal-title":"J. Hepatol."},{"key":"10.1016\/j.intimp.2019.05.012_bb0025","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/896864","article-title":"Clinical feature of intrahepatic B-lymphocytes in chronic hepatitis B","volume":"2014","author":"Mohamadkhani","year":"2014","journal-title":"Int. J. Inflamm."},{"issue":"5","key":"10.1016\/j.intimp.2019.05.012_bb0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0154815","article-title":"Overrepresentation of IL-10-expressing B cells suppresses cytotoxic CD4+ T cell activity in HBV-induced hepatocellular carcinoma","volume":"11","author":"Xue","year":"2016","journal-title":"PLoS One"},{"issue":"1 Suppl","key":"10.1016\/j.intimp.2019.05.012_bb0035","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1016\/j.jhep.2016.01.028","article-title":"The role of innate immunity in the immunopathology and treatment of HBV infection","volume":"64","author":"Maini","year":"2016","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.intimp.2019.05.012_bb0040","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1053\/j.gastro.2009.04.045","article-title":"Profile of tumor antigen-specific CD8 T cells in patients with hepatitis B virus-related hepatocellular carcinoma","volume":"137","author":"Gehring","year":"2009","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.intimp.2019.05.012_bb0045","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1007\/s12275-015-5314-y","article-title":"Regulation of HBV-specific CD8(+) T cell-mediated inflammation is diversified in different clinical presentations of HBV infection","volume":"53","author":"Dinney","year":"2015","journal-title":"J. Microbiol."},{"issue":"1","key":"10.1016\/j.intimp.2019.05.012_bb0050","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/jmedgenet-2018-105267","article-title":"Genetic and phenotypic difference in CD8+ T cell exhaustion between chronic hepatitis B infection and hepatocellular carcinoma","volume":"56","author":"Wang","year":"2019","journal-title":"J. Med. Genet."},{"issue":"4","key":"10.1016\/j.intimp.2019.05.012_bb0055","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S1074-7613(03)00267-X","article-title":"Blimp-1 is required for the formation of immunoglobulin secreting plasma cells and pre-plasma memory B cells","volume":"19","author":"Shapiro-Shelef","year":"2003","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.intimp.2019.05.012_bb0060","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/ni.3349","article-title":"Multifunctional role of the transcription factor Blimp-1 in coordinating plasma cell differentiation","volume":"17","author":"Minnich","year":"2016","journal-title":"Nat. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2019.05.012_bb0065","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/ni.3348","article-title":"Blimp-1 controls plasma cell function through the regulation of immunoglobulin secretion and the unfolded protein response","volume":"17","author":"Tellier","year":"2016","journal-title":"Nat. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2019.05.012_bb0070","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/ni1320","article-title":"Transcriptional repressor Blimp-1 regulates T cell homeostasis and function","volume":"7","author":"Martins","year":"2006","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2019.05.012_bb0075","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/0-387-46530-8_2","article-title":"Multiple roles for Blimp-1 in B and T lymphocytes","volume":"596","author":"Savitsky","year":"2007","journal-title":"Adv. Exp. Med. Biol."},{"issue":"12","key":"10.1016\/j.intimp.2019.05.012_bb0080","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/nri2204","article-title":"BLIMP1 guides the fate of effector B and T cells","volume":"7","author":"Nutt","year":"2007","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2019.05.012_bb0085","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.immuni.2009.06.021","article-title":"Blimp-1 transcription factor is required for the differentiation of effector CD8(+) T cells and memory responses","volume":"31","author":"Kallies","year":"2009","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.intimp.2019.05.012_bb0090","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/ni1321","article-title":"Transcriptional repressor Blimp-1 is essential for T cell homeostasis and self-tolerance","volume":"7","author":"Kallies","year":"2006","journal-title":"Nat. Immunol."},{"issue":"6284","key":"10.1016\/j.intimp.2019.05.012_bb0095","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1126\/science.aad2035","article-title":"Hobit and Blimp1 instruct a universal transcriptional program of tissue residency in lymphocytes","volume":"352","author":"Mackay","year":"2016","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.intimp.2019.05.012_bb0100","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-12171-3","article-title":"Differential regulation of effector and regulatory T cell function by Blimp1","volume":"7","author":"Bankoti","year":"2017","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.intimp.2019.05.012_bb0105","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s10875-007-9151-6","article-title":"Blimp-1 connects the intrinsic and extrinsic regulation of T cell homeostasis","volume":"28","author":"Nutt","year":"2008","journal-title":"J. Clin. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2019.05.012_bb0110","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.immuni.2009.06.019","article-title":"A role for the transcriptional repressor Blimp-1 in CD8(+) T cell exhaustion during chronic viral infection","volume":"31","author":"Shin","year":"2009","journal-title":"Immunity"},{"issue":"8","key":"10.1016\/j.intimp.2019.05.012_bb0115","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1172\/JCI66108","article-title":"Chronic viral infection promotes sustained Th1-derived immunoregulatory IL-10 via BLIMP-1","volume":"124","author":"Parish","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2019.05.012_bb0120","doi-asserted-by":"crossref","first-page":"e1694","DOI":"10.1038\/cddis.2015.42","article-title":"T-cell exhaustion in chronic hepatitis B infection: current knowledge and clinical significance","volume":"6","author":"Ye","year":"2015","journal-title":"Cell Death Dis."},{"issue":"11","key":"10.1016\/j.intimp.2019.05.012_bb0125","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1038\/ng.468","article-title":"A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus","volume":"41","author":"Gateva","year":"2009","journal-title":"Nat. Genet."},{"issue":"12","key":"10.1016\/j.intimp.2019.05.012_bb0130","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/ng.479","article-title":"Genetic variants at CD28, PRDM1 and CD2\/CD58 are associated with rheumatoid arthritis risk","volume":"41","author":"Raychaudhuri","year":"2009","journal-title":"Nat. Genet."},{"issue":"3","key":"10.1016\/j.intimp.2019.05.012_bb0135","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/ng.764","article-title":"Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47","volume":"43","author":"Anderson","year":"2011","journal-title":"Nat. Genet."},{"issue":"2","key":"10.1016\/j.intimp.2019.05.012_bb0140","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1053\/j.gastro.2013.04.040","article-title":"Association between variants of PRDM1 and NDP52 and Crohn's disease, based on exome sequencing and functional studies","volume":"145","author":"Ellinghaus","year":"2013","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.intimp.2019.05.012_bb0145","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1136\/annrheumdis-2016-210645","article-title":"Transethnic meta-analysis identifies GSDMA and PRDM1 as susceptibility genes to systemic sclerosis","volume":"76","author":"Terao","year":"2017","journal-title":"Ann. Rheum. Dis."},{"issue":"5","key":"10.1016\/j.intimp.2019.05.012_bb0150","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.3109\/10428194.2014.953155","article-title":"PRDM1\/BLIMP1: a tumor suppressor gene in B and T cell lymphomas","volume":"56","author":"Boi","year":"2015","journal-title":"Leuk. Lymphoma"},{"issue":"3","key":"10.1016\/j.intimp.2019.05.012_bb0155","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/leu.2016.243","article-title":"Loss of PRDM1\/BLIMP-1 function contributes to poor prognosis of activated B-cell-like diffuse large B-cell lymphoma","volume":"31","author":"Xia","year":"2017","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.intimp.2019.05.012_bb0160","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317695929","article-title":"Downregulation of PRDM1 promotes cellular invasion and lung cancer metastasis","volume":"39","author":"Zhu","year":"2017","journal-title":"Tumour Biol."},{"issue":"22","key":"10.1016\/j.intimp.2019.05.012_bb0165","doi-asserted-by":"crossref","first-page":"E5066","DOI":"10.1073\/pnas.1802902115","article-title":"PRDM1 silences stem cell-related genes and inhibits proliferation of human colon tumor organoids","volume":"115","author":"Liu","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.intimp.2019.05.012_bb0170","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.canlet.2013.01.005","article-title":"PRDM1 is directly targeted by miR-30a-5p and modulates the Wnt\/\u03b2-catenin pathway in a Dkk1-dependent manner during glioma growth","volume":"331","author":"Wang","year":"2013","journal-title":"Cancer Lett."},{"issue":"5","key":"10.1016\/j.intimp.2019.05.012_bb0175","first-page":"1449","article-title":"Effect of B lymphocyte-induced mature protein-1 expression in bone marrow mononuclear cells on prognosis of patients with multiple myeloma","volume":"25","author":"Liu","year":"2017","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"issue":"1","key":"10.1016\/j.intimp.2019.05.012_bb0180","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1038\/s41598-017-01332-z","article-title":"Dysregulation of Blimp1 transcriptional repressor unleashes p130Cas\/ErbB2 breast cancer invasion","volume":"7","author":"Sciortino","year":"2017","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.intimp.2019.05.012_bb0185","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1097\/QAD.0000000000000295","article-title":"Blimp-1 overexpression is associated with low HIV-1 reservoir and transcription levels in central memory CD4+ T cells from elite controllers","volume":"28","author":"de Masson","year":"2014","journal-title":"AIDS"},{"issue":"7","key":"10.1016\/j.intimp.2019.05.012_bb0190","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.4049\/jimmunol.1402581","article-title":"Blimp-1, an intrinsic factor that represses HIV-1 proviral transcription in memory CD4+ T cells","volume":"194","author":"Kaczmarek Michaels","year":"2015","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.intimp.2019.05.012_bb0195","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/j.humpath.2015.08.009","article-title":"PRDM1 expression via human parvovirus B19 infection plays a role in the pathogenesis of Hashimoto thyroiditis","volume":"46","author":"Wang","year":"2015","journal-title":"Hum. Pathol."},{"issue":"3","key":"10.1016\/j.intimp.2019.05.012_bb0200","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/leu.2015.285","article-title":"EBV-miR-BHRF1-2 targets PRDM1\/Blimp1: potential role in EBV lymphomagenesis","volume":"30","author":"Ma","year":"2016","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.intimp.2019.05.012_bb0205","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1084\/jem.20162115","article-title":"IL-2high tissue-resident T cells in the human liver: sentinels for hepatotropic infection","volume":"214","author":"Pallett","year":"2017","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.intimp.2019.05.012_bb0210","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/hep.29800","article-title":"Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance","volume":"67","author":"Terrault","year":"2018","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.intimp.2019.05.012_bb0215","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jhep.2011.12.001","article-title":"European Association For The Study Of The Liver; European Organisation For Research And Treatment Of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma","volume":"56","year":"2012","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.intimp.2019.05.012_bb0220","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1084\/jem.20130208","article-title":"Blimp-1 represses CD8 T cell expression of PD-1 using a feed-forward transcriptional circuit during acute viral infection","volume":"211","author":"Lu","year":"2014","journal-title":"J. Exp. Med."},{"issue":"9","key":"10.1016\/j.intimp.2019.05.012_bb0225","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1084\/jem.20151995","article-title":"Blimp-1-mediated CD4 T cell exhaustion causes CD8 T cell dysfunction during chronic toxoplasmosis","volume":"213","author":"Hwang","year":"2016","journal-title":"J. Exp. Med."},{"issue":"6","key":"10.1016\/j.intimp.2019.05.012_bb0230","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.jhep.2014.07.005","article-title":"Restoration of HBV-specific CD8+ T cell function by PD-1 blockade in inactive carrier patients is linked to T cell differentiation","volume":"61","author":"Bengsch","year":"2014","journal-title":"J. Hepatol."},{"issue":"28","key":"10.1016\/j.intimp.2019.05.012_bb0235","doi-asserted-by":"crossref","first-page":"46020","DOI":"10.18632\/oncotarget.17546","article-title":"Circulating soluble programmed death-1 levels may differentiate immune-tolerant phase from other phases and hepatocellular carcinoma from other clinical diseases in chronic hepatitis B virus infection","volume":"8","author":"Li","year":"2017","journal-title":"Oncotarget"},{"issue":"11","key":"10.1016\/j.intimp.2019.05.012_bb0240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0095870","article-title":"Circulating programmed death-1 as a marker for sustained high hepatitis B viral load and risk of hepatocellular carcinoma","volume":"9","author":"Cheng","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2019.05.012_bb0245","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ejca.2016.03.002","article-title":"High levels of the soluble programmed death-ligand (sPD-L1) identify hepatocellular carcinoma patients with a poor prognosis","volume":"59","author":"Finkelmeier","year":"2016","journal-title":"Eur. J. Cancer"},{"issue":"9","key":"10.1016\/j.intimp.2019.05.012_bb0250","doi-asserted-by":"crossref","first-page":"781","DOI":"10.5732\/cjc.010.10082","article-title":"Blimp-1 protein and Hans classification on prognosis of diffuse large B-cell lymphoma and their interrelation","volume":"29","author":"Song","year":"2010","journal-title":"Chin. J. Cancer"},{"key":"10.1016\/j.intimp.2019.05.012_bb0255","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.gde.2016.03.009","article-title":"The role of PRDMs in cancer: one family, two sides","volume":"36","author":"Mzoughi","year":"2016","journal-title":"Curr. Opin. Genet. Dev."},{"issue":"6","key":"10.1016\/j.intimp.2019.05.012_bb0260","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.4049\/jimmunol.170.6.3125","article-title":"Identification of a functionally impaired positive regulatory domain I binding factor 1 transcription repressor in myeloma cell lines","volume":"170","author":"Gy\u00f6ry","year":"2003","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2019.05.012_bb0265","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s12185-010-0689-3","article-title":"Loss of promoter methylation contributes to the expression of functionally impaired PRDM1\u03b2 isoform in diffuse large B-cell lymphoma","volume":"92","author":"Zhang","year":"2010","journal-title":"Int. J. Hematol."},{"issue":"4","key":"10.1016\/j.intimp.2019.05.012_bb0270","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/ni.3410","article-title":"A molecular threshold for effector CD8(+) T cell differentiation controlled by transcription factors Blimp-1 and T-bet","volume":"17","author":"Xin","year":"2016","journal-title":"Nat. Immunol."},{"issue":"10088","key":"10.1016\/j.intimp.2019.05.012_bb0275","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1016\/S0140-6736(17)31046-2","article-title":"Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1\/2 dose escalation and expansion trial","volume":"389","author":"El-Khoueiry","year":"2017","journal-title":"Lancet"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576919304540?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576919304540?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,22]],"date-time":"2019-09-22T02:38:53Z","timestamp":1569119933000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576919304540"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":55,"alternative-id":["S1567576919304540"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2019.05.012","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PRDM1 levels are associated with clinical diseases in chronic HBV infection and survival of patients with HBV-related hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2019.05.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}